Pharmaceutical Products for CDER Research Studies - IDIQ · FederalPipeline
Pharmaceutical Products for CDER Research Studies - IDIQ
Combined Synopsis/Solicitation from Food and Drug Administration, solicitation 75F40126Q132721. Responses due May 15, 2026. NAICS 325412. Listed on SAM.gov.